MedPath

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Obese Patients

Not Applicable
Conditions
Endotracheal Intubation
Desaturation
Ventilation
Obesity
Interventions
Device: orotracheal intubation Macintosh Laryngoscope
Device: orotracheal intubation Totaltrack VLM
Registration Number
NCT03106974
Lead Sponsor
AnestesiaR
Brief Summary

Airway management in obese patients has to consider that mask ventilation (DMV) risk is increased and difficult tracheal intubation (DTI) risk may be increased too.

In obese patients, is essential to prevent early arterial oxygen desaturation related to a reduced functional residual capacity (FRC), atelectasis formation during anesthetic induction and after tracheal intubation, because oxygenation maintenance is the cornerstone of the airway management of the obese patient.

Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However, sometimes this technique is ineffective and poorly tolerated by the obese patient.

The Totaltrack™ (MedComflow S.A., Barcelona, Spain) is a hybrid device, between a supraglottic airway and a videolaryngoscope with an anatomically shaped blade. It allows fibreoptic visualization of the larynx for tracheal intubation and was developed to aid both ventilation and tracheal intubation, at the time of anticipated and unanticipated difficult airway management.

However, despite its use in clinical practice, there are no comparative studies regarding direct laryngoscopy in obese patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1440
Inclusion Criteria
  • BMI > 30.
  • ASA 1-3
  • Scheduled surgeries that require orotracheal intubation.
  • General anesthesia with neuromuscular relaxation before intubation.
  • Patients who sign informed consent.
Exclusion Criteria
  • ASA 4
  • Difficult airway already known.
  • Alterations of airway documented, with previous tracheostomy or involve anatomical alterations.
  • General anesthesia that not require orotracheal intubation or neuromuscular relaxation.
  • Symptomatic gastro-esophageal reflux.
  • Lap-Band carrier.
  • Allergy medications to use.
  • Urgent surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Macintosh Laryngoscopeorotracheal intubation Macintosh Laryngoscopeorotracheal intubation (OTI) with Macintosh Laryngoscope Direct laryngoscopy
Totaltrack VLMorotracheal intubation Totaltrack VLMorotracheal intubation (OTI) with Totaltrack VlM Indirect laryngoscopy
Primary Outcome Measures
NameTimeMethod
saturation of blood oxygen at the end of orotracheal intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)

We will compare the blood oxygen saturation at the end of orotracheal intubation with macintosh and totaltrack.

The end of successful tracheal intubation will be established to obtain a curve of Capnography.

Secondary Outcome Measures
NameTimeMethod
number of maneuversTime of Orotracheal intubation (TOTI) (up to 1 hour)

number of maneuvers

Total time of successful intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)

Total time of successful intubation

IDS ScaleTime of Orotracheal intubation (TOTI) (up to 1 hour)

IDS Scale

POGO ScoreTime of Orotracheal intubation (TOTI) (up to 1 hour)

POGO Score

Number of attempts of endotracheal intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)

Number of attempts of endotracheal intubation

hemodynamic responseTOTI pre and postintubation (up to 10 minutes)

hemodynamic response

Degree of satisfaction of the researchertime of postintubation (up to 10 minutes)

Visual Analogic Scale (0-5)

adverse effects encountered during intubationTime of Orotracheal intubation (TOTI) (up to 1 hour)

adverse effects encountered during intubation

ComplicationsTime Frame: TOTI and postintubation (up to 24 hours)

Complications after intubation

Trial Locations

Locations (1)

Hospital Universitario Infanta Leonor

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath